MilliporeSigma Acquires BioControl to Strengthen Position in Food Safety Testing
- Acquisition complements MilliporeSigma’s existing products in food pathogen testing
- Enables MilliporeSigma to offer its customers complete workflow solutions for food pathogen testing
Billerica, Massachusetts, January 4, 2017 —MilliporeSigma today announced it has acquired BioControl Systems Inc., a global leader in food safety testing. The acquisition opens growth opportunities for MilliporeSigma in the food and beverage space, particularly in the U.S. Confidentiality has been agreed on the financial details of the transaction.
BioControl’s established rapid detection technology and third-party validated testing platforms complement MilliporeSigma’s portfolio of instruments and consumables in its applied solutions business geared to the food pathogen testing workflow.
“BioControl’s acquisition strengthens our ability to help customers protect the global food supply by providing an expansive portfolio of state-of-the-art testing technology,” said Udit Batra, Member of the Executive Board of Merck KGaA, Darmstadt, Germany and CEO, MilliporeSigma. “BioControl’s innovative assays and validated kits, when combined with MilliporeSigma’s strengths in microbiology, filtration and e-commerce will create a strong global provider aimed at solving tough challenges in the food pathogen testing space.”
The global spotlight on the importance of food safety has grown given the increased incidents of outbreaks and recalls with foodborne diseases often caused by consuming a wide range of foods including undercooked meat, eggs, fresh produce and dairy products contaminated by Salmonella, Listeria, E.coli O157H7 and Campylobacter. BioControl’s product portfolio includes pathogen detection kits to identify these food poisoning bacteria in food and ingredients and its key customers include meat producers.
“MilliporeSigma is the best home for Biocontrol, our customers and our employees,” said Phil Feldsine, President and Chief Executive of BioControl. “MilliporeSigma’s global market presence as a leader in laboratory sciences will introduce BioControl’s innovative, customer oriented solutions to a much broader base worldwide while providing existing customers with access to MilliporeSigma’s food safety product portfolio and expertise. The opportunity for BioControl to become part of a world class 350-year-old organization with a reputation for doing it the right way is very rewarding.”
The acquisition is in line with MilliporeSigma’s strategy to expand in key geographies and provide a differentiated experience to customers in applied settings, including food and beverage safety testing. While the business will continue to focus on microbial quality control solutions for pharmaceutical production processes and products, an area where the business currently has leading market share, the acquisition will enable MilliporeSigma to offer a complete food pathogen testing platform to its customers in the food and beverage safety testing market.
Achelous Partners acted as financial advisor to BioControl on this transaction. Nixon Peabody LLP represented MilliporeSigma in the transaction.
BioControl is one of the leading companies in innovative rapid microbiology tests for food safety for more than 30 years. It offers a diverse third party validated product portfolio lines, which include industrial microbiology testing, rapid detection methods for food-borne pathogens, the quantitative measurement of microorganisms, and hygiene monitoring. The company primarily sells its products to food manufacturers, ingredient suppliers, contract testing labs and government labs. BioControl is based in Bellevue, WA (U.S.), with over 100 employees worldwide. In FY 2015, it generated revenue of USD 34 million. For further details: visit www.biocontrolsys.com
All Merck KGaA, Darmstadt, Germany, press releases are distributed by e-mail at the same time they become available on the EMD Group Website. In case you are a resident of the USA or Canada please go to www.emdgroup.com/subscribe to register again for your online subscription of this service as our newly introduced geo-targeting requires new links in the email. You may later change your selection or discontinue this service.
Merck KGaA, Darmstadt, Germany
Merck KGaA, Darmstadt, Germany, is a leading science and technology company in healthcare, life science and performance materials. Around 50,000 employees work to further develop technologies that improve and enhance life – from biopharmaceutical therapies to treat cancer or multiple sclerosis, cutting-edge systems for scientific research and production, to liquid crystals for smartphones and LCD televisions. In 2015, Merck KGaA, Darmstadt, Germany, generated sales of € 12.85 billion in 66 countries.
Founded in 1668, Merck KGaA, Darmstadt, Germany, is the world's oldest pharmaceutical and chemical company. The founding family remains the majority owner of the publicly listed corporate group. Merck KGaA, Darmstadt, Germany, holds the global rights to the „Merck” name and brand. The only exceptions are the United States and Canada, where the company operates as EMD Serono, MilliporeSigma and EMD Performance Materials.
Merck KGaA, Darmstadt, Germany, announced the closing of the transaction to acquire M Chemicals Inc., the company recently incorporated by Mecaro Co. Ltd. to operate its chemical business.